Charles Schwab Investment Management Inc Calyxt, Inc. Transaction History

Charles Schwab Investment Management Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$3.83 - $6.31 $111,724 - $184,069	-29,171 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$4.25 - $12.01 $40,264 - $113,782	9,474 Added 48.1%	29,171 $176,000
Q3 2020 Nov 13, 2020	SELL	$4.37 - $7.66 $14,333 - $25,124	-3,280 Reduced 14.28%	19,697 $109,000
Q2 2020 Aug 14, 2020	SELL	$2.9 - $6.36 $33,248 - $72,917	-11,465 Reduced 33.29%	22,977 $114,000
Q1 2020 May 15, 2020	BUY	$2.48 - $7.85 $31,233 - $98,862	12,594 Added 57.64%	34,442 $115,000
Q2 2019 Aug 09, 2019	BUY	$12.24 - $17.4 $96,536 - $137,233	7,887 Added 56.49%	21,848 $273,000
Q4 2018 Feb 14, 2019	SELL	$9.33 - $14.99 $559 - $899	-60 Reduced 0.43%	13,961 $145,000
Q3 2018 Nov 13, 2018	BUY	$15.19 - $18.54 $212,978 - $259,949	14,021 New	14,021 $215,000
Q1 2018 May 07, 2018	SELL	$13.12 - $26.42 $191,552 - $385,732	-14,600 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$11.82 - $28.31 $172,572 - $413,326	14,600	14,600 $358,000

Ticker CLXT
Exchange NASDAQ
Sector Consumer Defensive
Industry Packaged Foods
Shares Outstandng 46,792,100
Market Cap $913M
Description
Calyxt, Inc., a synthetic biology company, engages in delivering plant-based solutions primarily to the agriculture end market in the United States. The company is involved in the development of improved digestibility alfalfa; hemp; and wheat with a higher fiber content. It has a commercialization agreement with S&W Seed Company for the excl...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.